Humanwell Short Term Debt from 2010 to 2024

600079 Stock   25.22  1.10  4.56%   
Humanwell Healthcare's Short Term Debt is increasing over the years with slightly volatile fluctuation. Short Term Debt is expected to dwindle to about 3.8 B. From 2010 to 2024 Humanwell Healthcare Short Term Debt quarterly data regression line had arithmetic mean of  3,258,858,895 and r-squared of  0.74. View All Fundamentals
 
Short Term Debt  
First Reported
2010-12-31
Previous Quarter
6.8 B
Current Value
3.8 B
Quarterly Volatility
2.7 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Humanwell Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Humanwell Healthcare's main balance sheet or income statement drivers, such as Interest Expense of 371.8 M, Selling General Administrative of 4.1 B or Total Revenue of 25.8 B, as well as many indicators such as . Humanwell financial statements analysis is a perfect complement when working with Humanwell Healthcare Valuation or Volatility modules.
  
This module can also supplement various Humanwell Healthcare Technical models . Check out the analysis of Humanwell Healthcare Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Humanwell Stock

Humanwell Healthcare financial ratios help investors to determine whether Humanwell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humanwell with respect to the benefits of owning Humanwell Healthcare security.